The present disclosure relates to an antibacterial composition comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof: especially for use against bacterial infection caused by a Gram negative bacteria, such as a kanamycin resistant bacteria an amikacin resistant bacteria, E. Coli or Pseudomonas aeruginosa.